Diabetes Mellitus
Insulin Therapy
Dr. Mohammad Daoud
Consultant Endocrinologist
KAMC/ NGHA - Jeddah –Saudi Arabia
Objectives
Introduction
Insulin :Choices and Profiles
Guidelines
Adding / Switching to Insulin
CASE:1
50 - Year-old female ; 8 years history of DM type 2
Meds: Metformin 1gm BD and Gliclazide MR 120 mg ,
Pioglitazone 30 mg ,and Sitagliptin 100 mg
Her diet and physical activity is excellent
Her glucose reading at home ; unsatisfactory
Last HbA1c 8.5- 9%
Best next step in management ?
CASE:2
61 - Year-old obese male patient
DM Type 2 for about 15 years
On maximum doses of MFN and SU
His FBS 180- 220 mg/dl (10-12 mmol/l)
Random readings 200-280 mg/dl (11-15.5 mmol/l)
HbA1c of 10.5 % - 11% despite being compliant to
treatment and diet
You are asked to help him getting better control?
Insulin
glargine
2000
Treatment Milestones in Diabetes
Biguanides
1960
Insulin
therapy
1922
Sulphonylurea
therapy
1950s
Insulin
pump
Late
1970s
NPH=neutral protamine Hagedorn; DCCT=Diabetes Control and Complications Trial; UKPDS=United Kingdom Prospective Diabetes Study.
Data from Tattersall RB. In: Pickup JC, Williams G, eds. Textbook of Diabetes. 3rd ed. Boston, Mass: Blackwell Science; 2003.
US FDA Center for Drug Evaluation and Research. Available at: http://www.fda.gov/cder/da/ddpa696.htm. Accessed 18 March 2003.
Lantus Consumer Information. Available at: http://www.fda.gov/cder/consumerinfo/druginfo/lantus.htm. Accessed 18 March 2003.
NPH
insulin
1946
Lente insulin
therapy
1952
HbA1c
testing
1975
DCCT
1993
Rapid-acting
insulin
analogues
1996
UKPDS
1998
Blood glucose
self-monitoring
GlycemicControl
Recommendations
EMPOWER the Patient
Should be able to
Use data
Adjust Therapy.
(E)
ADA. V. Diabetes Care. Diabetes Care 2014;37(suppl 1):S21–S22
ADA-2015
Correlation of A1C with
estimated Average Glucose
A1C (%) Mean plasma glucose mg/dl
6 ̴ 120
7 ̴ 150
8 ̴ 180
9 ̴ 210
10 ̴ 240
11 ̴ 270
12 ̴ 300
ADA. V. Diabetes Care. Diabetes Care 2014;37(suppl 1):S23; Table 8
Starting Insulin by M Daoud
Starting Insulin by M Daoud
Starting Insulin by M Daoud
Basal Insulin: Pharmacokinetics
Suppress hepatic glucose production
Maintain near normo-glycemia in the fasting state
Starting Insulin by M Daoud
Starting Insulin by M Daoud
Starting Insulin by M Daoud
Starting Insulin by M Daoud
Nutritional Insulin:
Meal related=Prandial
Control postprandial hyperglycemia
Starting Insulin by M Daoud
RAARAA RAA
RAA=
RAA RAA RAA
RAA=
Mixed Insulin
Humilin 70/30 or Mixtard
70% NPH , 30 % RI
Lispro-Mix 25/75 , 50/50
Lispro /Lispro protamine
Novo-Mix -30/70:
Aspart /Aspart protamine
Mix from two separate vials
Ex: RI and NPH
Mixed Insulin - ADA Guidelines
Not recommended for Type 1 DM patients
Type 2 DM patient: If well controlled …continue
Don’t mix Glargine / Detemir with other insulin :
Different PH
NPH + RI mixing …Use immediately
RAI (ex: Lispro / Aspart / Glulisine) + NPH ….
use within 15 minutes
Our Goal
To Mimic
Normal Physiology
CASE:1
50 - Year-old female ; 8 years history of DM type 2
Meds: Metformin 1gm BD and Gliclazide MR 120 mg ,
Pioglitazone 30 mg ,and Sitagliptin 100 mg
Excellent diet and physical activity
Body weight 70 kg, BMI 28
His SMBG at home ; Unsatisfactory
How will you asses her glycemic control ?
HbA1c
Glucose monitoring (SMBG)
How will you asses his glycemic control ?
HbA1c
Latest HbA1c 8.5 %- 9 %
What kind of monitoring will you do ?
Fasting , Pre-meals and @ Bed time
Vs
Fasting , Post-meals and @ Bed time
Starting Insulin by M Daoud
Case #1
With higher HbA1C :
Pre-meal glucose readings contribute more to
the HbA1C
With HbA1C closer to target ( ex: <8-8.5%)
Post-meal glucose readings contributes more to
the HbA1C value
Breakfast Lunch Dinner Bedtime
Before After Before After Before After
Day1 11.7 9.0 7.2 7.8
Day2 10.4 8.5 6.9
Day3 9.5 9.6 7.8
Day4 9.7 8.9 6.5
Day5 10.8 8.5 9.5
SMBG Record
Case #1 Summary
She is on maximum doses of oral agents…
still she has :
 Suboptimal glycemic control ; A1c >7%
 High BG levels, particularly in the morning
(fasting)
ADA-2015
InsulinRegimens
 Basal
 Basal +
 MDI
 Pre-mixed
What insulin regimen
would you prescribe?
Breakfast Lunch Dinner Bedtime
Before After Before After Before After
Day1 11.7 9.0 7.2 7.8
Day2 10.4 8.5 6.9
Day3 9.5 9.6 7.8
Day4 9.7 8.9 6.5
Day5 10.8 8.5 9.5
SMBG Record
Fasting / Pre-Prandial
80-130 mg /dl ~ 4.5 - 7.5 mmol/L
Post--Prandial
140-180 mg /dl ~ 8 - 10 mmol/L
Case #1
Basal insulin
Easy choice : single injection
(at bedtime)
“Breaks the Ice”
Starting Insulin by M Daoud
ADA 2015
Case #1
 Glargine or Detemir 15-20 units added at
Bedtime (weight 70 kg)
Or
Start a dose of 10 units
 Titrate every 2-3 days
 Pre-meal /FPG is at target :
80-130 mg/dl (about 4.5 - 7.5 mmol/L )
Case #1
3 months later : Now at 28 units of Glargine or
Detemir at Bedtime.... HbA1c 6.8%
Breakfast Lunch Dinner Bedtime
Before After Before After Before After
Day1 5.7 8.0 8.2 6.8
Day2 6.4 9.0 6.8
Day3 7.0 7.6 6.8
Day4 5.9 7.8 7.5
Day5 6.0 9.0 8.5
Case #1
Oral agents on board now ?
Metformin Keep unless CI
ISS /SU keep on board or decrease
DPP4 - Keep / less amount of insulin needed
Glitazones : Decrease
Watch for fluid retention/stop if needed
Case #1
4 years later : Now at 40 units of Glargine or
Detemir at Bedtime.... HbA1c 8.2%
Breakfast Lunch Dinner Bedti
me
Before After Before After Before After
Day1 7.5 9.0 12.5 8.2 9.8
Day2 6.9 11.9 9.0 10.5 11.8
Day3 6.8 7.6 10.2
Day4 5.9 13.0 7.8 9.9 9.5
Day5 7.5 9.0 12 8.5
Are you surprised ?
ADA=American Diabetes Association; HbA1c=hemoglobin A1c
Adapted from UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352: 854–865.
UKPDS: Glycemic Control Worsens Over TimeMedianHbA1c(%)
0 2 4
0
6
7
8
9
6 8 10
Time from Randomization (y)
Upper limit of normal range (6.2%)
ADA goal (7.0%)
Conventional (n=200) Insulin (n=199)
Chlorpropamide (n=129)Glibenclamide (n=148)
Metformin (n=181)
Diabetes Mellitus Type 2 is
a Progressive Disease
SA- GLA-11-11-04
43
When basal insulin is not enough
• Step 1: Think first of titrating the basal insulin dose till
reaching FBG target (Often under-dosage)
• Step 2: Shift to Basal Plus or Basal-bolus (MDI) regimen :
• Number of daily injections up to 4 (1+3)
• Inconvenience
• Risk of hypoglycemia & Weight gain
Add prandial insulin dose (s) as per guidelines
Case #1
4 years later : Now at 40 units of Glargine or Detemir at
Bedtime.... HbA1c 8.2%
Breakfast Lunch Dinner Bedtime
Before After Before After Before After
Day1 7.5 9.0 12.5 8.2 9.8
Day2 6.9 11.9 9.0 10.5 11.8
Day3 6.8 7.6 10.2
Day4 5.9 13.0 7.8 9.9 9.5
Day5 7.5 9.0 12 8.5
Post--Prandial
140-180 mg /dl ~ 8 - 10 mmol/L
Case #1
 Main issue now is post- prandial
hyperglycemia
 Add on : to main meal or all meals
RI / RAI
Ex : Aspart /Glulisine/ Lispro Insulin 4 u/ meal
Adjust according to SMBG
Basal +
ADA 2015
Starting Insulin by M Daoud
Case #1
Titrate every 2-3 days
Post-meal target
140-180 mg /dl (about 8- 10 mmol/L )
Case #1
3-4 months later : Now at 40 units of Glargine or Detemir
and Aspart 14- 12 -12- at Bedtime.... HbA1c 6.5%
Breakfast Lunch Dinner Bedtime
Before After Before After Before After
Day1 7.5 9.0 9.5 8.0 7.8
Day2 6.9 8.9 7.0 9.5 8.8
Day3 6.8 7.6 8.0
Day4 5.9 8.0 7.8 7.9 9.5
Day5 7.5 9.0 7.8 8.2
Well done
Case #1
Now on Basal 40 units
Meal related 38 units
Almost... 50% / 50%
Case #1
You may chose to use Basal +
i.e
Basal insulin + meal related insulin added to main meal or
the meal with highest post-prandial glucose
If not adequate …other meals can be covered also
Case #1
You may chose to use Premixed Insulin BID
Or
Premixed analogues :
Ex: NovoMix-30/70 or Humalog-Mix 25 in 2-3 doses
Mixed Insulins
ADA 2015
CASE: 2
68-year-old obese male patient
DM Type 2 for about 15 years
On SU and MFN maximum doses
His FPS 180- 220 mg/dl (> 10-12 mmol/l)
Random readings 200-280 mg/dl (> 11-15.5 mmol/l)
HbA1c of 10.5% despite compliance to Rx and TLC
You are asked to help him getting better control?
CASE:2
He has impaired vision
Polyuria , Polydypsia
(Weight 70 kg, Height 170 cm)
Serum Creatinine 1.15 mg/dl (105 nmol/L)
e-GFR ~ 50 ml/min
CASE:2
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 195 230 280 245
Day 2 180 200 205 230
Day 3 220 250 220 210
Case #2 Summary
Case review
 Uncontrolled / Symptomatic hyperglycemia
 High BG levels all over the screen ;
fasting and post-meals
 He is on maximum doses of oral agents
 Co-morbidities : Renal impairment +…
ADA/EASD and AACE position statement 2012:
individualized HbA1c targets
Inzucchi et al. Diabetologia 2012;55:1577–96
6.0 – 6.5% < 8.0%< 7.0%HbA1c target
CASE:2
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 195 230 280 245
Day 2 180 200 205 230
Day 3 220 250 220 210
What is the proper glycemic targets for this
patient ? Is it …
Fasting / Pre-Prandial
80-130 mg /dl ~ 4.5 - 7.5 mmol/L
Post--Prandial
140-180 mg /dl ~ 8 - 10 mmol/L
CASE:2
Before BF 2hr PBF Post Dinner 2hr PP
Day 1 195 230 280 245
Day 2 180 200 205 230
Day 3 220 250 220 210
Safer targets can be justified for this patient
Like…
Fasting / Pre-Prandial
100-150 mg /dl
Post--Prandial
150-200 mg /dl
•Age: Older adults
- Reduced life expectancy
- Higher CVD burden
- Reduced GFR
- At risk for adverse events from polypharmacy
- More likely to be compromised from hypoglycemia
Less ambitious targets
HbA1c <7.5–8.0% if tighter
targets not easily achieved
Focus on drug safety
Diabetes Care, Diabetologia. 19 April 2012 [Epub ahead of print]
Starting Insulin by M Daoud
CASE:2
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 195 230 280 245
Day 2 180 200 205 230
Day 3 220 250 220 210
Start TDD of 0.3- 0.5 unit /kg
Wt. 70 kg
0.4 unit /kg
(you can start with lower limit and adjust)
About 28 units total
CASE:2
TDD of 0.3- 0.5 up to 0.8 unit /kg
Wt 70 kg
0.4 unit /kg
Start at 28 units total
Then SMBG …and adjust
Basal/ Bolus
Glargine 16 u HS
RAI 4-4-4 u TID
Premixed
Mixtard 18/10
Aspart Mix (30/70)
18/10 OR 12-8-8
CASE:2
Started Premixed
Mixtard 18/10
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 195 230 280 245
Day 2 180 200 205 230
Day 3 220 250 220 210
CASE:2
Premixed
Mixtard 18/10
Dose adjusted gradually to
24 /14
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 145 150 188 125
Day 2 150 148 185 145
Day 3 152 140 190 150
CASE:2
4 weeks later
On Premixed
Mixtard 32 /16
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 122 89 138 75
Day 2 110 80 145 85
Day 3 116 100 120 70
CASE:2
2 months later
Premixed
Mixtard 32 /16
HbA1c 10.5 % to 8.6%
Frequent hypoglycemia ?!!
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 122 89 138 75
Day 2 110 60 195 55
Day 3 260 100 120 70
Starting Insulin by M Daoud
CASE:2
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 195 230 280 245
Day 2 180 200 205 230
Day 3 220 250 220 210
Basal/ Bolus
0.5 u/kg
18 units Detemir / Glargine
Aspart 6 units tid
CASE:2
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 144 200 120 195
Day 2 160 190 95 200
Day 3 175 200 110 210
1 week later
Increased Glargine …18 to 22 u
Increased Aspart …10 / 6 / 10
CASE:2
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 135 170 100 180
Day 2 150 160 110 190
Day 3 140 136 95 170
4 week later
Increased Glargine …22 to 26 units
Increased Aspart …10 / 6 / 12
CASE:2
Before BF 2hr PBF Pre Dinner 2hr PP
Day 1 135 150 100 150
Day 2 120 140 110 140
Day 3 110 136 95 160
3-4 Months later
Glargine …30units
Aspart …12 / 8 / 14
HbA1c 10.5% to 7.6%
CASE:2
Glargine …30units
Aspart …14 / 8 / 12
Basal 30 units
Prandial 34 units
Almost 50/50
0.5 to 0.9 u /kg
CASE: 2
Oral agents on board now ?
Metformin Keep unless CI
ISS /SU Stop
DPP4 - Keep / less amount of insulin needed
Glitazones : Decrease
Watch for fluid retention/stop if needed
To Conclude…
Starting Insulin by M Daoud
Summary(continue)
Basal Insulin alone …Break the Ice
0.1-0.3 u /kg or fixed 10 u and adjust
Early on , Don’t switch ….Add
(esp. insulin secretagogues; SU /Glinides)
Metformin: Keep unless CI
( Lower insulin doses and less weight gain)
TZDs …decrease or stop
(Less risk of fluid retention /heart failure)
Summary(continue)
Basal –Bolus Insulin
TDD = 0.3-0.5 u /kg
Basal Insulin 40-50 %
Meal related :50-60 %
Insulin secretagogues (SU /Glinides): No need
Keep Metformin / maybe TZDs
Summary(continue)
Premixed / Bi-Phasic
TDD = 0.3-0.5 u /kg
2/3 am and 1/3 pm OR
2-3 doses (premixed analogues)
10% adjustment role
Drawbacks:
Hypo /Weight gain/ Larger doses
Insulin secretagogues (SU /Glinides): No need
Keep Metformin / maybe TZDs
Summary
Start Low …and Go Slow …
monitor and adjust
Based on a “Trend”
Avoid hypoglycemia
Patient teaching …Core part of the team
https://www.aace.com
Education
Certification
.
.
Diabetes Resource Center
.
.
Inpatients Vs Outpatients

More Related Content

PPTX
SGLT2I The paradigm change in diabetes management
PPTX
DPP4 Inhibitors P4 Seminar2
PDF
Hyperlipidaemia
PDF
Case Study Type 1 Diabetes
PPSX
Insulin Initiation : When We should Start with Basal Insulin?
PPTX
Ryzodeg presentation in ramadan by dr shahjada selim
PPTX
Management of glycemic variability- Role of DPP4i (1).pptx
PPTX
Diabetic dyslipidemia
SGLT2I The paradigm change in diabetes management
DPP4 Inhibitors P4 Seminar2
Hyperlipidaemia
Case Study Type 1 Diabetes
Insulin Initiation : When We should Start with Basal Insulin?
Ryzodeg presentation in ramadan by dr shahjada selim
Management of glycemic variability- Role of DPP4i (1).pptx
Diabetic dyslipidemia

What's hot (20)

PPT
Dyslipidemia approach
PDF
Assessing Insulin Resistance
PPTX
Insulin therapy: art of initiation and titration
PPTX
Cpeptide &amp; diabetes dda 2015
PPTX
Diabetic Dyslipidemia Slide Share
PPTX
PPTX
Anti-Obesity Pharmacotherapy: Where are we now? Where are we going?
PPTX
Incretins In Diabetes Mellitus
PPT
Dyslipidemia
PPT
APPROACH TO DIABETES
PPTX
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
PPTX
Common errors in insulin therapy
PPTX
Empagliflozin
PPTX
sitagliptin for diabetics
PPTX
Diabetes Management during Ramadan by Dr Selim
PPTX
Hyperglycemia management
PPT
Diabetes mellitus by dr shahjada selim
PPTX
Hyperlipidemia
PPTX
Diabetes Mellitus Type 2
Dyslipidemia approach
Assessing Insulin Resistance
Insulin therapy: art of initiation and titration
Cpeptide &amp; diabetes dda 2015
Diabetic Dyslipidemia Slide Share
Anti-Obesity Pharmacotherapy: Where are we now? Where are we going?
Incretins In Diabetes Mellitus
Dyslipidemia
APPROACH TO DIABETES
Empagliflozin glycemic control and beyond-Dr Shahjada Selim
Common errors in insulin therapy
Empagliflozin
sitagliptin for diabetics
Diabetes Management during Ramadan by Dr Selim
Hyperglycemia management
Diabetes mellitus by dr shahjada selim
Hyperlipidemia
Diabetes Mellitus Type 2
Ad

Viewers also liked (20)

PPTX
Incretins based therapy :How Early
PPTX
Diabetes Mellitus and Fasting Ramadan may 2015
PPT
Registrar training talk
PDF
American Association of Clinical Endocrinologists’ Comprehensive Diabetes Man...
PPTX
Insulin: what is new ?
PPTX
Sub clinical thyroid dysfunction
PDF
Aace algorithm
PPTX
DM Lessons and Guidance
PPTX
HYPOTHYROIDIM Made Easy –Through Case Studies, Dr. Sharda jain
PPTX
Final control diabetes keep up to date 10 march 2016
PPTX
DCCT Learned Lessons
PPTX
AACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013
PPTX
Insulin choices for_diabetics
PPTX
subclinical hypothyrodism
PPT
Insulin therapy dr shahjadaselim
PPTX
Diabetic nephropathy management
PPTX
Diabetic nephropathy
PPT
diabetic nephropathy
PPTX
Diabetic ketoacidosis
PDF
PATHOPHYSIOLOGY OF DIABETIC NEPHROPATHY
Incretins based therapy :How Early
Diabetes Mellitus and Fasting Ramadan may 2015
Registrar training talk
American Association of Clinical Endocrinologists’ Comprehensive Diabetes Man...
Insulin: what is new ?
Sub clinical thyroid dysfunction
Aace algorithm
DM Lessons and Guidance
HYPOTHYROIDIM Made Easy –Through Case Studies, Dr. Sharda jain
Final control diabetes keep up to date 10 march 2016
DCCT Learned Lessons
AACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013
Insulin choices for_diabetics
subclinical hypothyrodism
Insulin therapy dr shahjadaselim
Diabetic nephropathy management
Diabetic nephropathy
diabetic nephropathy
Diabetic ketoacidosis
PATHOPHYSIOLOGY OF DIABETIC NEPHROPATHY
Ad

Similar to Starting Insulin by M Daoud (20)

PPT
Case studies in the managment of type 2 diabetes
PPTX
INDIVIDUALIZATION OF INSULIN THERAPY FOR T2D IN INDIAN SCENARIO.pptx
PPTX
3.Insulin Rx (1)-converted.pptx
PPT
Insulin therapy in type 2 diabetes
PDF
Insulin therapy in primary health care DrMajdi
PPTX
Early Initiation of Insulin:Basal bolus versus premixed insulin-Dr Shahjada S...
PDF
مدیریت و کنترل دیابت نوع دو (Management of diabetes)
PPTX
PREMIXED OR PRANDIAL INSULIN REGIMENS IN INSULIN NAÏVE.pptx
PPT
Insulin Therapy for Type 2 Diabetes:Update
PDF
Ueda2016 wark shop - insulin therapy - mohamed mashahit
PPTX
Ramadan and Insulin use for diabetic patients
PPT
Insulin 201 abbotsford
DOCX
Diabetes disease Management from scratch.docx
PPSX
Insulin intensification : the usage of premixed insulin after basal fails
PPTX
INSULIN THERAPY IN DIABETES MELLITUS - Copy.pptx
PPTX
Inpatient hyperglycemia.ver3 (3)
PDF
ueda2013 basal insulin versus premixed insulin-d.salah
PPTX
Scott, Ron Insulin Interventions.pptx
PPTX
Diabetes in clinical practice2
Case studies in the managment of type 2 diabetes
INDIVIDUALIZATION OF INSULIN THERAPY FOR T2D IN INDIAN SCENARIO.pptx
3.Insulin Rx (1)-converted.pptx
Insulin therapy in type 2 diabetes
Insulin therapy in primary health care DrMajdi
Early Initiation of Insulin:Basal bolus versus premixed insulin-Dr Shahjada S...
مدیریت و کنترل دیابت نوع دو (Management of diabetes)
PREMIXED OR PRANDIAL INSULIN REGIMENS IN INSULIN NAÏVE.pptx
Insulin Therapy for Type 2 Diabetes:Update
Ueda2016 wark shop - insulin therapy - mohamed mashahit
Ramadan and Insulin use for diabetic patients
Insulin 201 abbotsford
Diabetes disease Management from scratch.docx
Insulin intensification : the usage of premixed insulin after basal fails
INSULIN THERAPY IN DIABETES MELLITUS - Copy.pptx
Inpatient hyperglycemia.ver3 (3)
ueda2013 basal insulin versus premixed insulin-d.salah
Scott, Ron Insulin Interventions.pptx
Diabetes in clinical practice2

More from Mohammad Othman Daoud (10)

PPTX
Hyperglycemia for dm educators March 2016
PPTX
Hypoglycemi for dm educators
PPTX
GLP1 Role : DM type 2
PPTX
Dm medications cv safety
PPTX
Diabetic p. neuropathy
PPTX
Hyperglycemia emergency for dm educators
PPTX
Hypoglycemia in dm patients
PPTX
Dyslipdemia Guidelines Head to Head
PPTX
DM Standards of Care 2015 ;The ABcs
PPTX
Type 2 DM ; Metformin Best Partner
Hyperglycemia for dm educators March 2016
Hypoglycemi for dm educators
GLP1 Role : DM type 2
Dm medications cv safety
Diabetic p. neuropathy
Hyperglycemia emergency for dm educators
Hypoglycemia in dm patients
Dyslipdemia Guidelines Head to Head
DM Standards of Care 2015 ;The ABcs
Type 2 DM ; Metformin Best Partner

Recently uploaded (20)

PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PPTX
Hypertensive disorders in pregnancy.pptx
PDF
Impact of Technology on Patient Autonomy (www.kiu.ac.ug)
PPTX
Critical Issues in Periodontal Research- An overview
PDF
Gynecologic Malignancies.Dawit.pdf............
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPT
intrduction to nephrologDDDDDDDDDy lec1.ppt
PPTX
SHOCK- lectures on types of shock ,and complications w
PPTX
PARASYMPATHETIC NERVOUS SYSTEM and its correlation with HEART .pptx
PDF
The_EHRA_Book_of_Interventional Electrophysiology.pdf
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPT
Opthalmology presentation MRCP preparation.ppt
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPTX
HOP RELATED TO NURSING EDUCATION FOR BSC
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
Vaccines and immunization including cold chain , Open vial policy.pptx
Hypertensive disorders in pregnancy.pptx
Impact of Technology on Patient Autonomy (www.kiu.ac.ug)
Critical Issues in Periodontal Research- An overview
Gynecologic Malignancies.Dawit.pdf............
OSCE Series ( Questions & Answers ) - Set 6.pdf
nephrology MRCP - Member of Royal College of Physicians ppt
intrduction to nephrologDDDDDDDDDy lec1.ppt
SHOCK- lectures on types of shock ,and complications w
PARASYMPATHETIC NERVOUS SYSTEM and its correlation with HEART .pptx
The_EHRA_Book_of_Interventional Electrophysiology.pdf
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Opthalmology presentation MRCP preparation.ppt
Rheumatology Member of Royal College of Physicians.ppt
HOP RELATED TO NURSING EDUCATION FOR BSC

Starting Insulin by M Daoud

  • 1. Diabetes Mellitus Insulin Therapy Dr. Mohammad Daoud Consultant Endocrinologist KAMC/ NGHA - Jeddah –Saudi Arabia
  • 2. Objectives Introduction Insulin :Choices and Profiles Guidelines Adding / Switching to Insulin
  • 3. CASE:1 50 - Year-old female ; 8 years history of DM type 2 Meds: Metformin 1gm BD and Gliclazide MR 120 mg , Pioglitazone 30 mg ,and Sitagliptin 100 mg Her diet and physical activity is excellent Her glucose reading at home ; unsatisfactory Last HbA1c 8.5- 9% Best next step in management ?
  • 4. CASE:2 61 - Year-old obese male patient DM Type 2 for about 15 years On maximum doses of MFN and SU His FBS 180- 220 mg/dl (10-12 mmol/l) Random readings 200-280 mg/dl (11-15.5 mmol/l) HbA1c of 10.5 % - 11% despite being compliant to treatment and diet You are asked to help him getting better control?
  • 5. Insulin glargine 2000 Treatment Milestones in Diabetes Biguanides 1960 Insulin therapy 1922 Sulphonylurea therapy 1950s Insulin pump Late 1970s NPH=neutral protamine Hagedorn; DCCT=Diabetes Control and Complications Trial; UKPDS=United Kingdom Prospective Diabetes Study. Data from Tattersall RB. In: Pickup JC, Williams G, eds. Textbook of Diabetes. 3rd ed. Boston, Mass: Blackwell Science; 2003. US FDA Center for Drug Evaluation and Research. Available at: http://www.fda.gov/cder/da/ddpa696.htm. Accessed 18 March 2003. Lantus Consumer Information. Available at: http://www.fda.gov/cder/consumerinfo/druginfo/lantus.htm. Accessed 18 March 2003. NPH insulin 1946 Lente insulin therapy 1952 HbA1c testing 1975 DCCT 1993 Rapid-acting insulin analogues 1996 UKPDS 1998 Blood glucose self-monitoring
  • 6. GlycemicControl Recommendations EMPOWER the Patient Should be able to Use data Adjust Therapy. (E) ADA. V. Diabetes Care. Diabetes Care 2014;37(suppl 1):S21–S22
  • 8. Correlation of A1C with estimated Average Glucose A1C (%) Mean plasma glucose mg/dl 6 ̴ 120 7 ̴ 150 8 ̴ 180 9 ̴ 210 10 ̴ 240 11 ̴ 270 12 ̴ 300 ADA. V. Diabetes Care. Diabetes Care 2014;37(suppl 1):S23; Table 8
  • 12. Basal Insulin: Pharmacokinetics Suppress hepatic glucose production Maintain near normo-glycemia in the fasting state
  • 21. Mixed Insulin Humilin 70/30 or Mixtard 70% NPH , 30 % RI Lispro-Mix 25/75 , 50/50 Lispro /Lispro protamine Novo-Mix -30/70: Aspart /Aspart protamine Mix from two separate vials Ex: RI and NPH
  • 22. Mixed Insulin - ADA Guidelines Not recommended for Type 1 DM patients Type 2 DM patient: If well controlled …continue Don’t mix Glargine / Detemir with other insulin : Different PH NPH + RI mixing …Use immediately RAI (ex: Lispro / Aspart / Glulisine) + NPH …. use within 15 minutes
  • 24. CASE:1 50 - Year-old female ; 8 years history of DM type 2 Meds: Metformin 1gm BD and Gliclazide MR 120 mg , Pioglitazone 30 mg ,and Sitagliptin 100 mg Excellent diet and physical activity Body weight 70 kg, BMI 28 His SMBG at home ; Unsatisfactory
  • 25. How will you asses her glycemic control ? HbA1c Glucose monitoring (SMBG)
  • 26. How will you asses his glycemic control ? HbA1c Latest HbA1c 8.5 %- 9 %
  • 27. What kind of monitoring will you do ? Fasting , Pre-meals and @ Bed time Vs Fasting , Post-meals and @ Bed time
  • 29. Case #1 With higher HbA1C : Pre-meal glucose readings contribute more to the HbA1C With HbA1C closer to target ( ex: <8-8.5%) Post-meal glucose readings contributes more to the HbA1C value
  • 30. Breakfast Lunch Dinner Bedtime Before After Before After Before After Day1 11.7 9.0 7.2 7.8 Day2 10.4 8.5 6.9 Day3 9.5 9.6 7.8 Day4 9.7 8.9 6.5 Day5 10.8 8.5 9.5 SMBG Record
  • 31. Case #1 Summary She is on maximum doses of oral agents… still she has :  Suboptimal glycemic control ; A1c >7%  High BG levels, particularly in the morning (fasting)
  • 33. InsulinRegimens  Basal  Basal +  MDI  Pre-mixed What insulin regimen would you prescribe?
  • 34. Breakfast Lunch Dinner Bedtime Before After Before After Before After Day1 11.7 9.0 7.2 7.8 Day2 10.4 8.5 6.9 Day3 9.5 9.6 7.8 Day4 9.7 8.9 6.5 Day5 10.8 8.5 9.5 SMBG Record Fasting / Pre-Prandial 80-130 mg /dl ~ 4.5 - 7.5 mmol/L Post--Prandial 140-180 mg /dl ~ 8 - 10 mmol/L
  • 35. Case #1 Basal insulin Easy choice : single injection (at bedtime) “Breaks the Ice”
  • 38. Case #1  Glargine or Detemir 15-20 units added at Bedtime (weight 70 kg) Or Start a dose of 10 units  Titrate every 2-3 days  Pre-meal /FPG is at target : 80-130 mg/dl (about 4.5 - 7.5 mmol/L )
  • 39. Case #1 3 months later : Now at 28 units of Glargine or Detemir at Bedtime.... HbA1c 6.8% Breakfast Lunch Dinner Bedtime Before After Before After Before After Day1 5.7 8.0 8.2 6.8 Day2 6.4 9.0 6.8 Day3 7.0 7.6 6.8 Day4 5.9 7.8 7.5 Day5 6.0 9.0 8.5
  • 40. Case #1 Oral agents on board now ? Metformin Keep unless CI ISS /SU keep on board or decrease DPP4 - Keep / less amount of insulin needed Glitazones : Decrease Watch for fluid retention/stop if needed
  • 41. Case #1 4 years later : Now at 40 units of Glargine or Detemir at Bedtime.... HbA1c 8.2% Breakfast Lunch Dinner Bedti me Before After Before After Before After Day1 7.5 9.0 12.5 8.2 9.8 Day2 6.9 11.9 9.0 10.5 11.8 Day3 6.8 7.6 10.2 Day4 5.9 13.0 7.8 9.9 9.5 Day5 7.5 9.0 12 8.5 Are you surprised ?
  • 42. ADA=American Diabetes Association; HbA1c=hemoglobin A1c Adapted from UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352: 854–865. UKPDS: Glycemic Control Worsens Over TimeMedianHbA1c(%) 0 2 4 0 6 7 8 9 6 8 10 Time from Randomization (y) Upper limit of normal range (6.2%) ADA goal (7.0%) Conventional (n=200) Insulin (n=199) Chlorpropamide (n=129)Glibenclamide (n=148) Metformin (n=181) Diabetes Mellitus Type 2 is a Progressive Disease
  • 43. SA- GLA-11-11-04 43 When basal insulin is not enough • Step 1: Think first of titrating the basal insulin dose till reaching FBG target (Often under-dosage) • Step 2: Shift to Basal Plus or Basal-bolus (MDI) regimen : • Number of daily injections up to 4 (1+3) • Inconvenience • Risk of hypoglycemia & Weight gain Add prandial insulin dose (s) as per guidelines
  • 44. Case #1 4 years later : Now at 40 units of Glargine or Detemir at Bedtime.... HbA1c 8.2% Breakfast Lunch Dinner Bedtime Before After Before After Before After Day1 7.5 9.0 12.5 8.2 9.8 Day2 6.9 11.9 9.0 10.5 11.8 Day3 6.8 7.6 10.2 Day4 5.9 13.0 7.8 9.9 9.5 Day5 7.5 9.0 12 8.5 Post--Prandial 140-180 mg /dl ~ 8 - 10 mmol/L
  • 45. Case #1  Main issue now is post- prandial hyperglycemia  Add on : to main meal or all meals RI / RAI Ex : Aspart /Glulisine/ Lispro Insulin 4 u/ meal Adjust according to SMBG
  • 48. Case #1 Titrate every 2-3 days Post-meal target 140-180 mg /dl (about 8- 10 mmol/L )
  • 49. Case #1 3-4 months later : Now at 40 units of Glargine or Detemir and Aspart 14- 12 -12- at Bedtime.... HbA1c 6.5% Breakfast Lunch Dinner Bedtime Before After Before After Before After Day1 7.5 9.0 9.5 8.0 7.8 Day2 6.9 8.9 7.0 9.5 8.8 Day3 6.8 7.6 8.0 Day4 5.9 8.0 7.8 7.9 9.5 Day5 7.5 9.0 7.8 8.2 Well done
  • 50. Case #1 Now on Basal 40 units Meal related 38 units Almost... 50% / 50%
  • 51. Case #1 You may chose to use Basal + i.e Basal insulin + meal related insulin added to main meal or the meal with highest post-prandial glucose If not adequate …other meals can be covered also
  • 52. Case #1 You may chose to use Premixed Insulin BID Or Premixed analogues : Ex: NovoMix-30/70 or Humalog-Mix 25 in 2-3 doses
  • 54. CASE: 2 68-year-old obese male patient DM Type 2 for about 15 years On SU and MFN maximum doses His FPS 180- 220 mg/dl (> 10-12 mmol/l) Random readings 200-280 mg/dl (> 11-15.5 mmol/l) HbA1c of 10.5% despite compliance to Rx and TLC You are asked to help him getting better control?
  • 55. CASE:2 He has impaired vision Polyuria , Polydypsia (Weight 70 kg, Height 170 cm) Serum Creatinine 1.15 mg/dl (105 nmol/L) e-GFR ~ 50 ml/min
  • 56. CASE:2 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 195 230 280 245 Day 2 180 200 205 230 Day 3 220 250 220 210
  • 57. Case #2 Summary Case review  Uncontrolled / Symptomatic hyperglycemia  High BG levels all over the screen ; fasting and post-meals  He is on maximum doses of oral agents  Co-morbidities : Renal impairment +…
  • 58. ADA/EASD and AACE position statement 2012: individualized HbA1c targets Inzucchi et al. Diabetologia 2012;55:1577–96 6.0 – 6.5% < 8.0%< 7.0%HbA1c target
  • 59. CASE:2 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 195 230 280 245 Day 2 180 200 205 230 Day 3 220 250 220 210 What is the proper glycemic targets for this patient ? Is it … Fasting / Pre-Prandial 80-130 mg /dl ~ 4.5 - 7.5 mmol/L Post--Prandial 140-180 mg /dl ~ 8 - 10 mmol/L
  • 60. CASE:2 Before BF 2hr PBF Post Dinner 2hr PP Day 1 195 230 280 245 Day 2 180 200 205 230 Day 3 220 250 220 210 Safer targets can be justified for this patient Like… Fasting / Pre-Prandial 100-150 mg /dl Post--Prandial 150-200 mg /dl
  • 61. •Age: Older adults - Reduced life expectancy - Higher CVD burden - Reduced GFR - At risk for adverse events from polypharmacy - More likely to be compromised from hypoglycemia Less ambitious targets HbA1c <7.5–8.0% if tighter targets not easily achieved Focus on drug safety Diabetes Care, Diabetologia. 19 April 2012 [Epub ahead of print]
  • 63. CASE:2 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 195 230 280 245 Day 2 180 200 205 230 Day 3 220 250 220 210 Start TDD of 0.3- 0.5 unit /kg Wt. 70 kg 0.4 unit /kg (you can start with lower limit and adjust) About 28 units total
  • 64. CASE:2 TDD of 0.3- 0.5 up to 0.8 unit /kg Wt 70 kg 0.4 unit /kg Start at 28 units total Then SMBG …and adjust Basal/ Bolus Glargine 16 u HS RAI 4-4-4 u TID Premixed Mixtard 18/10 Aspart Mix (30/70) 18/10 OR 12-8-8
  • 65. CASE:2 Started Premixed Mixtard 18/10 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 195 230 280 245 Day 2 180 200 205 230 Day 3 220 250 220 210
  • 66. CASE:2 Premixed Mixtard 18/10 Dose adjusted gradually to 24 /14 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 145 150 188 125 Day 2 150 148 185 145 Day 3 152 140 190 150
  • 67. CASE:2 4 weeks later On Premixed Mixtard 32 /16 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 122 89 138 75 Day 2 110 80 145 85 Day 3 116 100 120 70
  • 68. CASE:2 2 months later Premixed Mixtard 32 /16 HbA1c 10.5 % to 8.6% Frequent hypoglycemia ?!! Before BF 2hr PBF Pre Dinner 2hr PP Day 1 122 89 138 75 Day 2 110 60 195 55 Day 3 260 100 120 70
  • 70. CASE:2 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 195 230 280 245 Day 2 180 200 205 230 Day 3 220 250 220 210 Basal/ Bolus 0.5 u/kg 18 units Detemir / Glargine Aspart 6 units tid
  • 71. CASE:2 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 144 200 120 195 Day 2 160 190 95 200 Day 3 175 200 110 210 1 week later Increased Glargine …18 to 22 u Increased Aspart …10 / 6 / 10
  • 72. CASE:2 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 135 170 100 180 Day 2 150 160 110 190 Day 3 140 136 95 170 4 week later Increased Glargine …22 to 26 units Increased Aspart …10 / 6 / 12
  • 73. CASE:2 Before BF 2hr PBF Pre Dinner 2hr PP Day 1 135 150 100 150 Day 2 120 140 110 140 Day 3 110 136 95 160 3-4 Months later Glargine …30units Aspart …12 / 8 / 14 HbA1c 10.5% to 7.6%
  • 74. CASE:2 Glargine …30units Aspart …14 / 8 / 12 Basal 30 units Prandial 34 units Almost 50/50 0.5 to 0.9 u /kg
  • 75. CASE: 2 Oral agents on board now ? Metformin Keep unless CI ISS /SU Stop DPP4 - Keep / less amount of insulin needed Glitazones : Decrease Watch for fluid retention/stop if needed
  • 78. Summary(continue) Basal Insulin alone …Break the Ice 0.1-0.3 u /kg or fixed 10 u and adjust Early on , Don’t switch ….Add (esp. insulin secretagogues; SU /Glinides) Metformin: Keep unless CI ( Lower insulin doses and less weight gain) TZDs …decrease or stop (Less risk of fluid retention /heart failure)
  • 79. Summary(continue) Basal –Bolus Insulin TDD = 0.3-0.5 u /kg Basal Insulin 40-50 % Meal related :50-60 % Insulin secretagogues (SU /Glinides): No need Keep Metformin / maybe TZDs
  • 80. Summary(continue) Premixed / Bi-Phasic TDD = 0.3-0.5 u /kg 2/3 am and 1/3 pm OR 2-3 doses (premixed analogues) 10% adjustment role Drawbacks: Hypo /Weight gain/ Larger doses Insulin secretagogues (SU /Glinides): No need Keep Metformin / maybe TZDs
  • 81. Summary Start Low …and Go Slow … monitor and adjust Based on a “Trend” Avoid hypoglycemia Patient teaching …Core part of the team